Market Definition

In the biomedical sciences, mathematical modelling has a long history. Mathematical and statistical approaches, in particular, have aided the advancement of the fields of population genetics and ecology. Systems biology involves biosimulation, which is computer mathematical modelling of biological processes and systems. Since biological processes are complex, simplified models are often used, which should be as complex as possible. The aim of biosimulations is to predict the actions and dynamics of biological systems using models, such as the body's or individual cells' responses to chemicals. The accuracy of model-based predictions, on the other hand, is highly influenced by the model's quality, which is determined by the data quality and depth of information. The market's growth is expected to be fueled by a high clinical urgency to develop high-potency and innovative drugs. Researchers' interest in biosimulation is expected to grow as a result of technological advancements and software upgrades on a regular basis.

Report Scope

The global market report scope includes a detailed study covering underlying factors influencing the industry trends. The report covers analysis of regional and country-level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes a detailed competitive outlook covering market shares and profiles key participants in the market share.

Major Market Players

Some of the key players operating in the market are Certara, Simulation Plus, Dassault Systèmes, Schrödinger, Advanced Chemistry Development, Chemical Computing Group, Rosa, Physiomics, Evidera, In Silico Biosciences, Leadinvent Technologies, Inosim Software, Nuventra Pharma, Accelrys, Entelos, Physiomics, Rhenovia, Insilico Biotechnology, LeadScope, Genedata, Archimedes, Compugen among others.

The Biosimulation Market report has been categorized as below

By Product & Service

  • Software
  • Molecular Modeling and Simulation Software
  • PBPK Modeling and Simulation Software
  • PK/PD Modeling and Simulation Software
  • Trial Design Software
  • Toxicity Prediction Software
  • Other Biosimulation Software
  • Services
  • In-house Services
  • Contract Services

By Application

  • Drug Development
  • Preclinical Testing
  • PK/PD
  • ADME/TOX
  • Clinical Trials
  • Drug Discovery    
  • Target Identification and Validation
  • Lead Identification and Optimization
  • Other Applications              

By Delivery Model

  • Subscription Models
  • Ownership Models

By End User

  • Pharmaceutical and Biotechnology Companies
  • Research Institutes
  • Contract Research Organizations
  • Regulatory Authorities
  • Other End Users

By Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of World 

The years considered for the study are as follows:

  • Base year - 2020
  • Estimated year - 2021
  • Projected year - 2022
  • Forecast period - 2021 to 2027

Key Questions Addressed by the Report

  • New products/service competitor are exploring?
  • Key players in the Biosimulation Market and how intense is the competition?
  • What are the upcoming industry trends that manufacturers are focusing on in the future updates?
  • For each segment, what are the significant opportunities in the market?
  • What are the key growth strategies adopted by major market players in the market?
  • What are the key success strategies adopted by major competitors in the market?

 Why Buy this Report:

  • Gain comprehensive insights on the Biosimulation Market trends
  • Note complete analysis of the market status
  • Recognize the market opportunities and growth segments
  • Evaluating business segments & product portfolios, and interpret competitive dynamics
  • Facilitate strategy planning and industry dynamics to strengthen decision making

Report Table Of Content

1.   Simulation Market Introduction

1.1. Key Insights

1.2. Report Overview

1.3. Markets Covered

1.4. Stakeholders

2.   Research Methodology

2.1. Research Scope

2.2. Market Research Process

2.3. Research Data Analysis

2.4. Market Size Estimation

3.   Executive Summary

4.   Market Overview

4.1.   Introduction

4.2.   Market Drivers and Restraints

5.   By Product & Services

5.1.   Key Points

5.2.   Software

5.3.   Services

6.   By Application

6.1.   Key Points

6.2.   Drug Development

6.3.   Drug Discovery

6.4.   Other

7.   By Delivery Mode

7.1. Subscription Models

7.2. Ownership Models

8.   By End User

8.1. Pharmaceutical and Biotechnology Companies

8.2. Research Institutes

8.3. Contract Research Organizations

8.4. Regulatory Authorities

The Biosimulation Market report has been categorized as below

By Product & Service

  • Software
  • Molecular Modeling and Simulation Software
  • PBPK Modeling and Simulation Software
  • PK/PD Modeling and Simulation Software
  • Trial Design Software
  • Toxicity Prediction Software
  • Other Biosimulation Software
  • Services
  • In-house Services
  • Contract Services

By Application

  • Drug Development
  • Preclinical Testing
  • PK/PD
  • ADME/TOX
  • Clinical Trials
  • Drug Discovery    
  • Target Identification and Validation
  • Lead Identification and Optimization
  • Other Applications              

By Delivery Model

  • Subscription Models
  • Ownership Models

By End User

  • Pharmaceutical and Biotechnology Companies
  • Research Institutes
  • Contract Research Organizations
  • Regulatory Authorities
  • Other End Users

By Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of World 

Licence Option

  • Single User-  1500 USD
  • Multiple User-  3500 USD

Buy
Quality assurance

A testimonial for service in the form of BBB “A” Accreditation.

Your personal and confidential information is safe and secure.

  - Information security

© 2021 Whipsmart. All Rights Reserved.